UNSPSC 85818807: Transfusion of autologous frozen plasma into central artery, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to transfusion of autologous frozen plasma into central artery, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 30260K0

UNSPSC 85818807 Transfusion of autologous frozen plasma into central artery, open approach is a Commodity code that shows minimal alignment between its nominal scope and the state and local procurement activity currently tagged to it. The recent opportunities block contains six solicitations, none of which involve transfusion services, autologous plasma procedures, or open-approach vascular interventions. Instead, the tagged opportunities span occupational medical surveillance (Washington State Ferries), independent medical evaluations for public safety pension disability determinations (City of Phoenix), surgical and medical procedure carve-out benefit programs through Centers of Excellence (City of Long Beach), emergency and inpatient hospital services for youth in custody (Harris County), pharmacy benefit management (Collier County), and temporary health professional staffing across ancillary clinical categories (Santa Clara County Health System). These solicitations reflect administrative healthcare procurement, benefits management, and clinical staffing—not the surgical transfusion procedure the code nominally describes.

The mismatch suggests either systematic miscoding of these opportunities or a data-entry error in the taxonomy assignment. State and local procurement offices do solicit medical services under UNSPSC codes, but the range and nature of work tagged here bears no meaningful relationship to autologous frozen plasma transfusion via open central artery approach. The code appears to see little or no genuine procurement activity aligned with its stated scope. Businesses evaluating pursuit under this code should verify the accuracy of any future opportunities tagged to it before committing business development resources, as the current block does not represent actionable market activity for transfusion or open-approach vascular procedures.